Natriuretic peptide system: Physiology and clinical utility

Current Opinion in Critical Care

Volumn 10, Issue 5, 2004, Pages 336-341

  Suttner, Stefan W ^a,b   Boldt, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Acute coronary syndrome; Atrial natriuretic peptide; Biomarker; Brain natriuretic peptide; Heart failure; Natriuretic peptides

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NESIRITIDE; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; RENIN;

ACUTE HEART FAILURE; ADRENERGIC SYSTEM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG MECHANISM; HEART DEATH; HEART FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPOTENSION; NATRIURESIS; PROTEIN METABOLISM; PROTEIN STRUCTURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; VASODILATATION;

AMINO ACID SEQUENCE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PROGNOSIS;

EID: 4744342432     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000135513.26376.4f     Document Type: Review

References (27)

1. De Bold AJ, Borenstein HB, Veress AT, et al.: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981, 28:89-94.
2. Kangawa K, Matsuo H: Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984, 118:131-139.
3. Sudoh T, Kangawa K, Minamino N, et al.: A new natriuretic peptide in porcine brain. Nature 1988, 332:78-81.
4. Hosoda K, Nakao K, Mukoyama M, et al.: Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension 1991, 17:1152-1155.
5. Barr CS, Rhodes P, Struthers AD: C-type natriuretic peptide. Peptides 1996, 17:1243-1251.
6. Schweitz H, Vigne P, Moinier D, et al.: A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 1992, 267:13928-13932.
7. Schirger JA, Heublein DM, Chen HH, et al.: Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin Proc 1999, 74:126-130.
8. Baughman KL: B-type natriuretic peptide - a window to the heart. N Engl J Med 2002, 347:158-159.
9. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998, 339:321-328.
10. Stein BC, Levin RI: Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998, 135:14-23.
11. Schultz HD, Gardner DG, Deschepper CF, et al.: Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol 1988, 155:R6-R13.
12. Marin-Grez M, Fleming JT, Steinhausen M: Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986, 324:473-476.
13. Hunt PJ, Richards AM, Espiner EA, et al.: Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 1994, 78:428-435.
14. Mark DB, Felker GM: B-type natriuretic peptide - a biomarker for all seasons. N Engl J Med 2004, 350:718-720.
15. Maisel AS, Krishnaswamy P, Nowak RM, et al.: Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
16. Richards AM, Nicholls GM, Espiner EA, et al.: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792.
17. Mueller C, Scholer A, Laule-Kilian K, et al.: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004, 350:647-654.
18. McCullough PA, Nowak RM, McCord J, et al.: B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure: analysis from the Breathing Not Properly (BNP) Multinational Study. Circulation 2002, 106:416-422.
19. McCullough PA, Duc P, Omland T, et al.: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003, 41:571-579.
20. McLean AS, Huang SJ, Nalos M, et al.: The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003, 31:2611-2618.
21. Berger R, Huelsman M, Strecker K, et al.: B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002, 105:2392-2397.
22. Maeda K, Tsutamoto T, Wada A, et al.: High level of plasma BNP at discharge is an independent risk factor for mortality and morbidity in patients with congestive heart failure. J Am Coll Cardiol 1999, 192:1113-1140.
23. De Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362:1-7.
24. De Lemos JA, Morrow DA, Bentley JH, et al.: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021.
25. Troughton RW, Frampton CM, Yandle TG, et al.: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000, 355:1126-1130.
26. Kawai K, Haka K, Takaoka H, et al.: Plasma brain natriuretic peptide as a novel indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment. Am Heart J 2001, 141:925-932.
27. Colucci W, Elkayam U, Horton DP, et al.: For the Nesiritide study group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000, 343:246-253.